# INTERNATIONAL COMPLIANCE FRAMEWORK — AION-BRAIN

**Document Classification:** International Regulatory Guidance Index  
**Effective Date:** November 2025  
**Version:** 2.0  
**Scope:** Global Regulatory Frameworks  
**License:** Apache License 2.0

---

## Overview

This directory provides guidance on international regulatory frameworks applicable to AI systems in healthcare, legal, financial, and security domains. AION-BRAIN users deploying in specific jurisdictions must comply with all applicable local regulations.

---

## Regulatory Framework Index

### Healthcare/Medical AI Regulations

| Jurisdiction | Regulatory Body | Framework Document |
|--------------|-----------------|-------------------|
| **European Union** | EMA, National Authorities | [EU-MDR-COMPLIANCE.md](EU-MDR-COMPLIANCE.md) |
| **United Kingdom** | MHRA | [UK-MHRA-GUIDANCE.md](UK-MHRA-GUIDANCE.md) |
| **Canada** | Health Canada | [HEALTH-CANADA-REQUIREMENTS.md](HEALTH-CANADA-REQUIREMENTS.md) |
| **Japan** | PMDA | [JAPAN-PMDA-STANDARDS.md](JAPAN-PMDA-STANDARDS.md) |
| **China** | NMPA | [CHINA-NMPA-REGULATIONS.md](CHINA-NMPA-REGULATIONS.md) |
| **Australia** | TGA | [AUSTRALIA-TGA-FRAMEWORK.md](AUSTRALIA-TGA-FRAMEWORK.md) |
| **India** | CDSCO | [INDIA-CDSCO-FRAMEWORK.md](INDIA-CDSCO-FRAMEWORK.md) |
| **South Korea** | MFDS | [SOUTH-KOREA-MFDS-FRAMEWORK.md](SOUTH-KOREA-MFDS-FRAMEWORK.md) |
| **Brazil** | ANVISA | [BRAZIL-ANVISA-FRAMEWORK.md](BRAZIL-ANVISA-FRAMEWORK.md) |
| **South Africa** | SAHPRA | [SOUTH-AFRICA-SAHPRA-FRAMEWORK.md](SOUTH-AFRICA-SAHPRA-FRAMEWORK.md) |
| **United States** | FDA | [../FDA-REGULATORY-STATUS.md](../FDA-REGULATORY-STATUS.md) |

---

## AION-BRAIN International Position

### Universal Disclaimer

AION-BRAIN is NOT a regulated product in any jurisdiction:

```
AION-BRAIN REGULATORY STATUS (ALL JURISDICTIONS)
═══════════════════════════════════════════════════════════════

✗ NOT a medical device under any regulatory framework
✗ NOT a legal service provider in any jurisdiction  
✗ NOT a financial services product anywhere
✗ NOT a certified security solution globally

✓ Open-source research infrastructure
✓ Apache 2.0 licensed documentation
✓ Educational and development resource
✓ Starting point requiring local validation
```

### User Responsibility

Users deploying AION-BRAIN-derived products in any jurisdiction are solely responsible for:

1. Determining applicable regulatory requirements
2. Obtaining required approvals and certifications
3. Maintaining ongoing compliance
4. Reporting adverse events as required
5. Engaging qualified local regulatory affairs professionals

---

## Key International Frameworks

### Medical Device / Software as Medical Device (SaMD)

| Framework | Scope | Key Documents |
|-----------|-------|---------------|
| **IMDRF** | Global harmonization | SaMD Classification, Clinical Evaluation |
| **ISO 13485** | Quality management | Medical device QMS |
| **IEC 62304** | Software lifecycle | Medical device software development |
| **ISO 14971** | Risk management | Medical device risk management |

### Data Protection / Privacy

| Framework | Jurisdiction | Key Requirements |
|-----------|--------------|------------------|
| **GDPR** | EU/EEA | Data protection, consent, DPIAs |
| **UK GDPR** | United Kingdom | Post-Brexit data protection |
| **LGPD** | Brazil | Brazilian data protection law |
| **PDPA** | Singapore | Personal data protection |
| **PIPL** | China | Personal information protection |
| **APPI** | Japan | Personal information protection |
| **Privacy Act** | Australia | Australian privacy principles |
| **DPDP Act** | India | Digital Personal Data Protection Act 2023 |
| **PIPA** | South Korea | Personal Information Protection Act |
| **LGPD** | Brazil | Lei Geral de Protecao de Dados |
| **POPIA** | South Africa | Protection of Personal Information Act |

### AI-Specific Regulations (Emerging)

| Regulation | Jurisdiction | Status |
|------------|--------------|--------|
| **EU AI Act** | European Union | Effective 2024-2026 |
| **AI Safety Framework** | United Kingdom | Guidance issued |
| **AI Principles** | OECD | Advisory framework |
| **AI Risk Management** | NIST (US) | Voluntary framework |
| **AI Basic Act** | South Korea | Effective 2026 |
| **Generative AI Guidelines** | South Korea (MFDS) | World's first (January 2025) |

---

## Compliance Decision Tree

```
USER COMPLIANCE DECISION TREE
═══════════════════════════════════════════════════════════════

START: Using AION-BRAIN in [JURISDICTION]?
       │
       ├─► What domain?
       │   │
       │   ├─► Healthcare/Medical
       │   │   └─► Check medical device regulations
       │   │       └─► Determine if YOUR product is SaMD
       │   │           └─► If yes → Approval pathway required
       │   │
       │   ├─► Legal
       │   │   └─► Check legal practice regulations
       │   │       └─► Determine UPL requirements
       │   │           └─► Ensure licensed oversight
       │   │
       │   ├─► Financial
       │   │   └─► Check financial services regulations
       │   │       └─► Determine registration requirements
       │   │           └─► Obtain required licenses
       │   │
       │   └─► Security
       │       └─► Check certification requirements
       │           └─► Obtain required certifications
       │               └─► Maintain compliance
       │
       └─► ALL PATHS REQUIRE:
           ├─► Local regulatory affairs professional
           ├─► Local legal counsel
           ├─► Documentation of compliance
           └─► Ongoing monitoring
```

---

## Contact for Regulatory Questions

**General Inquiries:** AIONSYSTEM@outlook.com

**Important:** AION-BRAIN cannot provide regulatory advice. Engage qualified regulatory affairs professionals in your target jurisdiction(s).

---

## Document Control

| Version | Date | Author | Changes |
|---------|------|--------|---------|
| 1.0 | Nov 2025 | AION-BRAIN | Initial draft |
| 2.0 | Nov 2025 | AION-BRAIN | Comprehensive international framework |

---

**Document Version:** 2.0  
**Effective Date:** November 2025  
**License:** Apache License 2.0

*This document is part of the AION-BRAIN Legal Framework*
